천연식물자원으로부터 Acetylcholine esterase 저해 활성 탐색 및 인지기능에 미치는 영향
Screeening of Natural Plant Resources with Acetylcholine esterase inhibitory activity and Effect on Scopolamine-induced Memory Impairment
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
아세틸콜린 분해효소(acetylcholine esterase, AChE) 억제제는 아세틸콜린 함량을 높여 콜린성 neuron을 활성화함으로써 기억 능력의 개선 및 치매 개선을 가져와 현재 다양한 AChE 억제제들이 개발되어 사용되고 있다. 본 연구에서는 AChE에 대한 억제 활성을 갖는 천연물을 다양한 식물추출물 및 에센스오일로부터 탐색하였으며, 탐색한 추출물의 scopolamine으로 기억손상을 유발한 쥐의 기억력 개선 활성을 치매 치료제로 사용하고 있는 donepizil과 비교 분석하였다. 그 결과 자몽(Citrus paradisi) 유래의 에센스 오일이 AChE 억제 활성이 가장 높아 20 ug/ml의 농도로 처리하였을 때 90% 이상의 효소 억제 활성을 나타내었다. 수동회피 실험 결과, 자몽 유래의 에센스오일(100 mg/kg, p.o.)을 투여한 쥐는 치매 치료제로 사용하고 있는 donepizile (0.5 mg/kg)을 투여한 쥐와 유사한 latency time을 나타내어 인지기능이 개선되었다. 또한, 수중미로 시험 결과, 자몽 유래 에센스오일(100 mg/Kg, p.o.)을 투여한 쥐는 donepizile(0.5 mg/kg)을 투여한 쥐와 유사한 latency time을 나타내어 인지기능이 개선되었다. 이상의 결과로부터 자몽 유래 에센스오일은 매우 효과적으로 기억력을 개선하여 인지기능을 개선해 줄 수 있는 안전하고 효과적인 후보물질이라고 사료된다.
Abstract
This study was performed to investigate the effect of essential oils and ethanolic extracts of approximately 650 plant species on acetylcholine esterase (AChE) enzyme activity using Ellman's colorimetric method in 96-well microplates. The results showed that the ethanolic extracts from twig of Sophora subprostrata, twig of Phellodendron amurense, seed of Corylopsis coreana, and essential oil (EO) from Citrus paradisi, Cupressus sempervirens, Ocimum basilicum, Pinus sylvestris and Rosmarinus officinalis inhibited more than 80% of AChE activity. Among these, EO from Pinus sylvestris, C. sempervirens and C paradisi exhibited higher values of AChE inhibitory activity, which were 75, 84 and 99% at a concentration of 50 ug/ml, respectively. Finally, EO from C paradisi (grapefruit, GEO) showed the highest inhibitory activity towards AChE, which showed 91% of inhibition at a concentration of 20 ug/ml. We also examined the anti-dementia effects of GEO in mouse by passive avoidance test and Morris water maze test. The model mouse (male, ICR) of dementia (negative control) was induced by administration of scopolamine (1 mg/kg body weight). The latency time of sample group administrated with GEO (100 mg/kg, p.o.) increased significantly as compared with negative control on passive avoidance test. There were significant recovery from the scopolamine-induced deficits on learning and memory in water maze test through daily administrations with GEO (100 mg/kg, p.o.). From these results, we conclude that GEO treatment might enhance the cognitive function, suggesting that the EO of C. paradis may be a potential candidate for improvement of perceptive ability and dementia.
참고문헌 (46)
- Adams R. L., "Neuropsychology of dementia", Neurolog. Clin, 4, pp.387~405 (1984)
- Barnham K. J., "Neurodegenerative diseases and oxidative stress", Nature. Rev. Drug Discovery, 3, pp.205~214 (2004)
- Borjesson-Hanson A., "The prevalence of dementia in 95 year olds", Neurol, 63, pp.2436~2438 (2004)
- Butini S., "Tacrine based human cholinesterase inhibitors: Synthesis of peptidic-tethered derivatives and their effect on potency and selectivity", Bioorganic Med. Chem. Lett, 18, pp.5213~5216 (2008)
- Chung Y. K., "Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase", Mol. Cells, 11, pp.137~143 (2001)
- Citron M., "Strategies for disease modification in Alzheimer's disease", Nature Rev. Neurosci, 5, pp.677~685 (2004)
- Cottingham M. G., "The intact human acetylcholinesterase c-terminal oligomerization domain is alpha-helical in situ and in isolation, but a shorter fragment forms beta-sheet-rich amyloid fibrils and protofibrillar oligomers", Biochem, 42, pp.10863~10873 (2003)
- Cummings J. L., "Cholinesterase inhibitors: a new class of psychotropic compounds", Am. J. Psychiatry, 157, pp.4~15 (2000)
- Cummings J. L., "Alzheimer's Disease", Nwe. Engl. J. Med, 351, pp.56~67 (2004)
- de Lau, L. M., "Epidemiology of Parkinson's disease", Lancet Neurol, 5, pp.525~535 (2006)
- Ellman G. L., "A new and rapid colorimetric determination of acetylcholinesterase activity", Biochem. Pharmacol, 7, pp.88~95 (1961)
- Enz A., "Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease", Prog. Brain Res, 98, pp.431~445 (1993)
- Fayuk D., "Regulation of nicotinic acetylcholine receptor channel function by acetylcholinesterase inhibitors in rat hippocampal CA1 interneurons", Mol. Pharmacol, 66, pp.658~666 (2004)
- Findeis M. A., "The role of amyloid β peptide 42 in Alzheimer's disease", Pharmacol. Therapeut, 116, pp.266~286 (2007)
- Grossberg G., "Rivastigmine in Alzheimer's disease: efficacy over two years", Am. J. Geriatr. Psychiatry, 12, pp.420~431 (2004)
- Ingkaninan K., "Screening for acetylcholin esterase inhibitory activity in plants used in Thai traditional rejuvenating and neurotonic remedies", J. Ethnopharmacol, 89, pp.261~264 (2003)
- Johnson N. T. D., "The epidermic of Alzheimer's disease", Pharmacoeconomics, 18, pp.215~223 (2000)
- 이 신 영, "Hericium erinaceum 액체배양 생성물의 Acetyl-cholinesterase 저해 활성과 항산화 활성", KSBB Journal, 22(1), pp.30~36 (2007), 한국생물공학회
- Kalauni S. K., "New cholinesterase inhibiting steroidal alkaloids from the leaves of Sarcococca coriacea of Nepalese origin", Chem. Pharm. Bull, 50, pp.1423~1426 (2002)
- 김대익, "천연 식물자원으로부터 Acetylcholinesterase 저해 및 항산화 활성 탐색", 한국식품영양과학회지, 34(3), pp.427~432 (2005), 한국식품영양과학회
- 김대경, "BF-7의 기억력 및 인지기능 향상효과", Anatomy and Cell Biology, 37(6), pp.519~527 (2004), 대한해부학회
- 김정섭, "생약추출물들의 acetylcholinesterase (AChE) 저해활성검색", 생약학회지, 33(3), pp.211~218 (2002), 한국생약학회
- 이은희, "한국의 알츠하이머병 환자에서 아세틸콜린 에스터레이스 억제제의 뇌척수액 베타아밀로이드 1-42 분획과 인산화타우단백 농도에 미치는 효과", 대한신경과학회지, 26(3), pp.224~230 (2008), 대한신경과학회
- 이미라, "백삼과 홍삼추출물의 학습수행과 Acetylcholinesterase 억제에 미치는 효과", Journal of Ginseng Research, 32(4), pp.341~346 (2008), 고려인삼학회
- 이미라, "녹용 추출물이 치매 동물모델의 기억력 개선과 관련효소 활성에 미치는 효과", 한국식품영양과학회지, 38(4), pp.409~414 (2009), 한국식품영양과학회
- Lemiere J., "Treatment of Alzheimer's disease: an evaluation of cholinergic approach", Acta Neurol. Belg, 99, pp.96~106 (1999)
- Mattson M.P, "Pathways towards and away from Alzheimer's disease", Nature, 430, pp.631~639 (2004)
- Nussbaum R. L., "Alzheimer's disease and Parkinson's disease", New Engl. J. Med, 348, pp.1356~1364 (2003)
- Park C. H., "Novel anticholinesterase and antiamnesic activities of dehydroevodiamine, a constituent of Evodia rutaecarpa", Planta Med, 62, pp.405~409 (1996)
- 이상한, "해바라기씨 추출물의 뇌세포에 대한 사멸 보호 효과", 한국식품저장유통학회지, 14(2), pp.213~219 (2007), 한국식품저장유통학회
- Reale M., "The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients", Neuropharmacol, 50, pp.606~613 (2006)
- Rosengarten B., "Acetylcholine esterase inhibitor donepezil improves dynamic cerebrovascular regulation in Alzheimer patients", J. Neurol, 253, pp.58~64 (2006)
- 류병호, "초석잠 메탄올 추출물의 Acetylcholine Esterase 및 Monoamine Oxidase 활성 억제 효과", 한국식품영양학회지, 17(4), pp.347~355 (2004), 한국식품영양학회
- 류승엽, "Studies on the Acetylcholinesterase inhibitors Effects of Cuscutae Semen", 대한본초학회지, 18(4), pp.32~300 (2003), 대한본초학회
- Sabbagh M. N., "Drug Development for Alzheimer's Disease: Where Are We Now and Where Are We Headed", Am. J. Geriatric Pharmacother, 7, pp.167~185 (2009)
- Sharp B. M., "Effects of Galantamine, a Nicotinic Allosteric Potentiating Ligand, on Nicotine-Induced Catecholamine Release in Hippocampus and Nucleus Accumbens of Rats", J. Pharmacol. Experimental Therapeut, 309, pp.1116~1123 (2004)
- Silvestrelli G., "Treatment of Alzheimer's disease: from pharmacology to a better understanding of disease pathophysiology", Mech. Ageing Dev, 127, pp.148~157 (2006)
- 손추영, "신약 개발을 위한 참당귀(Angelica gigas Nakai) 추출 Decursin과 Decursinol Angelate의 약리 작용", 약 학 회 지, 53(6), pp.300~313 (2009), 대한약학회
- Suh, G. H., "The economic costs of dementia in Korea", Int. J. Geriatr Psychiatry, 21, pp.722~728 (2006)
- Sung S. H., "(+)-α-Viniferin, a Stilbene Trimer from Caragana chamlague, Inhibits Acetylcholinesterase", Biol. Pharm. Bull, 25, pp.125~127 (2002)
- Wang P., "Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine", Acta Pharmacologica Sinica, 27, pp.1~26 (2006)
- Watanabe T., "Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's disease", Brain Res, 1249, pp.222~228 (2009)
- Wenk G. L., "Neuropathologic changes in Alzheimer's disease: potential targets for treatment", J. Clin. Psychiatry, 67, pp.3~7 (2006)
- Wilkinson D. G., "Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy", Drugs Aging, 21, pp.453~478 (2004)
- 윤미영, "석곡MeOH 추출물이 H2O2에의한신경세포 보호효과에 미치는 영향", Journal of the Korean Society for Applied Biological Chemistry, 50(1), pp.63~67 (2007), 한국응용생명화학회
- Zotova E., "Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy", Alzheimer's Res. Therapy, 2, pp.1~9 (2010)
